Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
Radheshyam Meher, Senior Resident at AIIMS, reposted from International Society of Blood Transfusion (ISBT) on LinkedIn, adding:
“Honoured to be featured as a contributor to the Transfusion Evidence Round-Up– International Childhood Cancer Day 2026, an initiative by the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL), in collaboration with the ISBT Cellular Therapies Working Party.
This special edition highlights key advances at the intersection of Transfusion Medicine, Paediatric Haematology and Cellular Therapies. Being part of an international editorial team committed to translating evidence into clinical practice has been both a privilege and a learning experience.
Grateful to my colleagues and mentors across the global transfusion and cell therapy community for their collaboration and dedication to advancing patient care. I look forward to continued contributions that bridge science, clinical practice, and education.
Thanks to International Society of Blood Transfusion (ISBT) and Allison Mo for providing me this wonderful opportunity.”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
“Last Sunday marked International Childhood Cancer Day, and to recognise the occasion, we’ve teamed up with the ISBT Cellular Therapies Working Group to share a special joint Round-Up highlighting the latest developments in Transfusion Medicine and Cell Therapy.
In this edition, we take a closer look at research shaping paediatric haematology and stem cell transplantation, including insights from the FORUM Trial on how minimal residual disease influences outcomes in childhood acute lymphoblastic leukaemia. We also explore progress in TCRαβ/CD19-depleted haematopoietic stem cell transplantation, second transplant strategies for relapsed acute myeloid leukaemia, and outcomes following CAR-T therapy in children and young people.
Whether you work in transfusion, cell therapy research, or have an interest in paediatric oncology, this curated top-ten selection brings together valuable insights from across both fields.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies